Clinical Trial: Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07177352) titled 'Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies' on Sept. 15.

Brief Summary: This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Study Start Date: July 02

Study Type: INTERVENTIONAL

Condition: Alzheimers Disease

Intervention: OTHER: No Intervention

Participants will have their blood drawn and cognitive score measured by the ISLT.

Recruitment Status: RECRUITING

Sponsor: Hoffmann-La Roche

Published by HT Digital Content Services with permission from Health Daily Digest....